glp 1 microdose for inflammation GLP-1 Injections Microdosing GLP-1 | AgelessRx

Both semaglutide and tirzepatide have not been studied extensively in pregnant women, but animal studies suggest potential risks to fetal development, including: Fetal growth restriction Structural abnormalities Miscarriage (observed in animal studies at high doses) Stillbirth, animal studies show risk at all doses

These are peptides that each have anti-inflammatory, wound-healing, and tissue regenerating properties

A required part of this site couldnt load

10.3389/fphar.2025.1562896 73 Svegliati-BaroniG.SaccomannoS.RychlickiC.AgostinelliL.De MinicisS.CandelaresiC.et al (2011)

And its, which is pro grow and we dont always want to grow, right

[2] While patients taking tirzepatide (the active ingredient in Mounjaro) lost 22.5% of their weight in 72 weeks, when combined with diet and exercise changes